During the past decade, Policlinica Barcelona conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Policlinica Barcelona" #1 collaborator was "Simbec Research" with 1 trials as a collaborator, "Syneos Health" with 1 trials as a collaborator and "bioRASI, LLC" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Policlinica Barcelona" are "Acute Respiratory Infection" (1 trials), "Fibrosis" (1 trials), "IPF" (1 trials), "Idiopathic Pulmonary Fibrosis" (1 trials) and "Idiopathic Pulmonary Fibrosis (IPF)" (1 trials). Many other conditions were trialed in "Policlinica Barcelona" in a lesser frequency.

Most popular intervention types in "Policlinica Barcelona" are "Drug" (3 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "BI 1015550" (1 trials), "GB0139" (1 trials), "Nasal Swab Sample" (1 trials) and "RXC007" (1 trials). Other intervention names were less common.

The vast majority of trials in "Policlinica Barcelona" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Policlinica Barcelona". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Policlinica Barcelona, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Policlinica Barcelona, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".